• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃博拉病毒:从发现到疫苗

Ebola virus: from discovery to vaccine.

作者信息

Feldmann Heinz, Jones Steven, Klenk Hans-Dieter, Schnittler Hans-Joachim

机构信息

Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.

出版信息

Nat Rev Immunol. 2003 Aug;3(8):677-85. doi: 10.1038/nri1154.

DOI:10.1038/nri1154
PMID:12974482
Abstract

Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre- and post-exposure interventions makes the development of rapid diagnostics, new antiviral agents and protective vaccines a priority for many nations. Further insight into the ecology, immunology and pathogenesis of Ebola virus will promote the delivery of these urgently required tools.

摘要

埃博拉病毒对人类和非人类灵长类动物具有高度致病性,并且曾是武器计划的研究对象,如今是全球最令人恐惧的病原体之一。此外,由于缺乏暴露前和暴露后干预措施,开发快速诊断方法、新型抗病毒药物和保护性疫苗成为许多国家的优先事项。对埃博拉病毒的生态学、免疫学和发病机制的进一步了解将推动这些急需工具的提供。

相似文献

1
Ebola virus: from discovery to vaccine.埃博拉病毒:从发现到疫苗
Nat Rev Immunol. 2003 Aug;3(8):677-85. doi: 10.1038/nri1154.
2
A single shot against Ebola and Marburg virus.针对埃博拉病毒和马尔堡病毒的单次注射。
Nat Med. 2005 Jul;11(7):720-1. doi: 10.1038/nm0705-720.
3
Towards a vaccine against Ebola virus.迈向埃博拉病毒疫苗
Expert Rev Vaccines. 2003 Dec;2(6):777-89. doi: 10.1586/14760584.2.6.777.
4
Evaluation in nonhuman primates of vaccines against Ebola virus.在非人类灵长类动物中对埃博拉病毒疫苗进行评估。
Emerg Infect Dis. 2002 May;8(5):503-7. doi: 10.3201/eid0805.010284.
5
[Hope for a vaccine against ebola virus].[对抗埃博拉病毒疫苗的希望]
Pharm Unserer Zeit. 2001;30(3):185-6.
6
Development of a preventive vaccine for Ebola virus infection in primates.用于灵长类动物埃博拉病毒感染的预防性疫苗的研发。
Nature. 2000 Nov 30;408(6812):605-9. doi: 10.1038/35046108.
7
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.复制缺陷型重组腺病毒 5 型疫苗表达埃博拉病毒 GP,在健康成年人中是安全和有免疫原性的。
Vaccine. 2010 Dec 16;29(2):304-13. doi: 10.1016/j.vaccine.2010.10.037. Epub 2010 Oct 27.
8
Virology. New vaccine and treatment excite Ebola researchers.病毒学。新型疫苗与疗法令埃博拉研究人员兴奋不已。
Science. 2003 Nov 14;302(5648):1141-2. doi: 10.1126/science.302.5648.1141.
9
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.减毒活重组疫苗可保护非人灵长类动物免受埃博拉病毒和马尔堡病毒感染。
Nat Med. 2005 Jul;11(7):786-90. doi: 10.1038/nm1258. Epub 2005 Jun 5.
10
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.基于埃博拉病毒样颗粒的疫苗可保护非人灵长类动物免受致命埃博拉病毒的攻击。
J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7. doi: 10.1086/520583.

引用本文的文献

1
Drug repositioning as a promising approach for the eradication of emerging and re-emerging viral agents.药物重新定位作为一种有前景的方法,用于根除新出现和再次出现的病毒病原体。
Mol Divers. 2025 Mar 18. doi: 10.1007/s11030-025-11131-8.
2
Assessing the ecological resilience of Ebola virus in Africa and potential influencing factors based on a synthesized model.基于综合模型评估非洲埃博拉病毒的生态恢复力及潜在影响因素。
PLoS Negl Trop Dis. 2025 Feb 7;19(2):e0012843. doi: 10.1371/journal.pntd.0012843. eCollection 2025 Feb.
3
Biomechanics Model to Characterize Atomic Force Microscopy-Based Virus-Host Cell Adhesion Measurements.
用于表征基于原子力显微镜的病毒-宿主细胞粘附测量的生物力学模型
J Phys Chem B. 2024 Nov 28;128(47):11546-11553. doi: 10.1021/acs.jpcb.4c04527. Epub 2024 Sep 24.
4
Control strategies for emerging infectious diseases: Crimean-Congo hemorrhagic fever management.新发传染病的防控策略:克里米亚-刚果出血热的管理
Health Sci Rep. 2024 Sep 2;7(9):e70053. doi: 10.1002/hsr2.70053. eCollection 2024 Sep.
5
Evaluation of fendiline treatment in VP40 system with nucleation-elongation process: a computational model of Ebola virus matrix protein assembly.评价 VP40 系统中芬迪林治疗的核延伸过程:埃博拉病毒基质蛋白组装的计算模型。
Microbiol Spectr. 2024 Apr 2;12(4):e0309823. doi: 10.1128/spectrum.03098-23. Epub 2024 Feb 26.
6
Long-Term Clinical Safety of the Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: A Prospective, Multi-Country, Observational Study.Ad26.ZEBOV和MVA-BN-Filo埃博拉疫苗的长期临床安全性:一项前瞻性、多国观察性研究。
Vaccines (Basel). 2024 Feb 17;12(2):210. doi: 10.3390/vaccines12020210.
7
Exploring Alternative Care Platforms for Symptomatic People in the Fight against the Ebola Virus Disease Outbreak.探索在抗击埃博拉病毒病疫情中为出现症状者提供替代护理的平台。
J Immunol Sci. 2023 May 12;Suppl 3:81-87. doi: 10.29245/2578-3009/2023/S3.1106.
8
Ebola virus sequesters IRF3 in viral inclusion bodies to evade host antiviral immunity.埃博拉病毒将 IRF3 隔离在病毒包含体中,以逃避宿主抗病毒免疫。
Elife. 2024 Jan 29;12:RP88122. doi: 10.7554/eLife.88122.
9
Elucidation of prognostic factors in the acute phase of feline severe fever with thrombocytopenia syndrome virus infection.阐明猫严重发热伴血小板减少综合征病毒感染急性期的预后因素。
J Vet Med Sci. 2024 Feb 15;86(2):211-220. doi: 10.1292/jvms.22-0427. Epub 2023 Dec 29.
10
Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication.埃博拉病毒 VP35 扰乱 I 型干扰素信号转导以促进病毒复制。
Virol Sin. 2023 Dec;38(6):922-930. doi: 10.1016/j.virs.2023.10.004. Epub 2023 Oct 13.